Message from the CEO 

We are pleased to announce the establishment of GEXVal Inc., a research and development-oriented drug discovery startup focused on the development of treatment for intractable and rare diseases. We launched our business at Shonan Health Innovation Park in Fujisawa, Kanagawa on April 1, 2018.

Together with our colleagues, we share the passion of “Bringing a smile to patients and their families’ faces”. 

Development of drugs for orphan and intractable diseases is a very challenging mission in drug discovery. “People with the right talent and expertise”, “individuals who can take risks”, “high quality seeds”, and “supporters and sufficient funding” are essential for accomplishing our mission.  

“The patient comes first!” is our motto. With high quality seeds, we will put our best and tireless efforts into strategic and efficient R&D activity to deliver innovative drugs for patients who have long awaited treatment that can improve their lives. 

 

April 1, 2018
Juran Kato
President & CEO
GEXVal Inc.